Correlation Between Bio Techne and Verve Therapeutics

Can any of the company-specific risk be diversified away by investing in both Bio Techne and Verve Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bio Techne and Verve Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Bio Techne Corp and Verve Therapeutics, you can compare the effects of market volatilities on Bio Techne and Verve Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bio Techne with a short position of Verve Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bio Techne and Verve Therapeutics.

Diversification Opportunities for Bio Techne and Verve Therapeutics

0.2

Correlation Coefficient

Bio Techne  Verve Therapeutics

Modest diversification

The 3 months correlation between Bio and Verve is 0.2. Overlapping area represents the amount of risk that can be diversified away by holding Bio Techne Corp and Verve Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Verve Therapeutics and Bio Techne is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bio Techne Corp are associated (or correlated) with Verve Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Verve Therapeutics has no effect on the direction of Bio Techne i.e., Bio Techne and Verve Therapeutics go up and down completely randomly.

Pair Corralation between Bio Techne and Verve Therapeutics

Given the investment horizon of 90 days Bio Techne is expected to generate 3.86 times less return on investment than Verve Therapeutics. But when comparing it to its historical volatility, Bio Techne Corp is 2.44 times less risky than Verve Therapeutics. It trades about 0.05 of its potential returns per unit of risk. Verve Therapeutics is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  565.00  in Verve Therapeutics on September 12, 2024 and sell it today you would earn a total of  107.00  from holding Verve Therapeutics or generate 18.94% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Bio Techne Corp  vs.  Verve Therapeutics

Bio Techne Corp

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Bio Techne Corp are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite fairly weak fundamental indicators, Bio Techne may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Verve Therapeutics

Risk-Adjusted Performance

5 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Verve Therapeutics are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain basic indicators, Verve Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Bio Techne and Verve Therapeutics

The main advantage of trading using opposite Bio Techne and Verve Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bio Techne position performs unexpectedly, Verve Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Verve Therapeutics will offset losses from the drop in Verve Therapeutics' long position.

The idea behind Bio Techne Corp and Verve Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.